Category News

VitriVax Secures $87 Million Series C Funding to Advance Lyme Disease Vaccine Candidate into Clinical Development and Expand Pipeline

VitriVax Raises $87 Million in Oversubscribed Series C Financing to Advance Lyme Disease Vaccine and Expand ALTA® Technology Pipeline VitriVax, a vaccine development and formulation technology company, has announced the successful close of an oversubscribed $87 million Series C financing…

Read MoreVitriVax Secures $87 Million Series C Funding to Advance Lyme Disease Vaccine Candidate into Clinical Development and Expand Pipeline

Thermo Fisher Scientific Introduces Gibco™ VaxEvo™ CD 293 Medium to Enhance Adenovirus Vaccine Manufacturing

Thermo Fisher Scientific Launches Gibco™ VaxEvo™ CD 293 Medium to Support Scalable Adenovirus Vaccine Production Thermo Fisher Scientific, a global leader in serving science, has announced the launch of Gibco™ VaxEvo™ CD 293 Medium, a new chemically defined and animal…

Read MoreThermo Fisher Scientific Introduces Gibco™ VaxEvo™ CD 293 Medium to Enhance Adenovirus Vaccine Manufacturing

C2N Diagnostics Expands Blood Test Portfolio with Next-Generation Brain Amyloid Assay for Alzheimer’s Research

C2N Diagnostics Launches New Plasma Aβ Multi-Analyte Assay to Advance Alzheimer’s Disease Research and Drug Development C2N Diagnostics, LLC, a pioneer in advanced diagnostic testing for brain health, has announced the launch of a novel plasma multi-analyte assay (MAA) designed…

Read MoreC2N Diagnostics Expands Blood Test Portfolio with Next-Generation Brain Amyloid Assay for Alzheimer’s Research

Ossa, Powered by B-Secur, Launches Q5 Platform to Transform Workforce Wellbeing Data Into Actionable Insights

B-Secur Launches Ossa Workforce Wellbeing Programme to Help Global Organisations Reduce Employee Burnout and Absence Costs B-Secur has announced the launch of Ossa, a managed workforce wellbeing programme designed to help organisations address employee burnout, reduce workforce absence costs, and…

Read MoreOssa, Powered by B-Secur, Launches Q5 Platform to Transform Workforce Wellbeing Data Into Actionable Insights

Genetix Announces Transformation Into a Profitable, High-Growth Commercial Leader in Rare Disease Genetic Medicine

Genetix Biotherapeutics Reports Strong 2026 Commercial Growth, Achieves Profitability and Targets Multibillion-Dollar Expansion Genetix Biotherapeutics Inc., a commercial leader in genetic medicines for rare diseases with a primary focus on hematology, has announced a significant transformation into a profitable, high-growth…

Read MoreGenetix Announces Transformation Into a Profitable, High-Growth Commercial Leader in Rare Disease Genetic Medicine

Ollin Biosciences to Be Acquired, Advancing Development of Next-Generation Treatments for Vision-Threatening Eye Diseases

Ollin Biosciences to Be Acquired, Supporting the Development of Innovative Treatments for Vision-Threatening Eye Diseases Johnson & Johnson has entered into a definitive agreement to acquire Ollin Biosciences, Inc., a privately held clinical-stage biopharmaceutical company focused on developing innovative treatments…

Read MoreOllin Biosciences to Be Acquired, Advancing Development of Next-Generation Treatments for Vision-Threatening Eye Diseases

HeartBeam Announces Third Quarter 2026 Financial Results and Business Update

HeartBeam Reports Third Quarter 2026 Financial Results, Advances Heart Attack Assessment Strategy and Prepares for Pivotal U.S. Study HeartBeam, a medical technology company focused on transforming cardiac care through personalized cardiac insights, has announced its financial and operational results for…

Read MoreHeartBeam Announces Third Quarter 2026 Financial Results and Business Update

HSS Research Identifies Improved Approaches to Predict Inflammation in Rheumatoid Arthritis

Hospital for Special Surgery Presents Three Studies Exploring Precision Medicine Approaches to Improve Rheumatoid Arthritis Treatment Hospital for Special Surgery (HSS) researchers have presented findings from three new studies aimed at improving the assessment of joint inflammation and supporting more…

Read MoreHSS Research Identifies Improved Approaches to Predict Inflammation in Rheumatoid Arthritis

Dreem Health and Withings Partner to Transform Sleep Tracking Into Comprehensive Sleep Care

Dreem Health Partners with Withings to Connect Wearable Sleep Data with Personalized Clinical Care Dreem Health, in collaboration with Sunrise Group, has announced a partnership with wearable technology company Withings to help users turn their sleep-tracking data into actionable medical…

Read MoreDreem Health and Withings Partner to Transform Sleep Tracking Into Comprehensive Sleep Care

101 Therapeutics Presents Positive Phase 2/3 Data for Macrophage-Targeted 101-PGC-005 at ACR 2026

101 Therapeutics Presents Phase 2/3 Clinical Data for CD206-Targeted Therapy 101-PGC-005 at ACR Convergence 2026 101 Therapeutics Ltd., a clinical-stage biotechnology company focused on developing macrophage-targeted therapeutics for inflammatory and immune-mediated diseases, has presented clinical data and a development rationale…

Read More101 Therapeutics Presents Positive Phase 2/3 Data for Macrophage-Targeted 101-PGC-005 at ACR 2026